01/09/2026
2nd Meeting of the Regional Pharmacovigilance Committee, Islamabad.
The 2nd meeting of the Regional Pharmacovigilance Committee (RPC), Islamabad was held today under the chairmanship of Dr Rashida Batool, the Chairperson of the Committee. The meeting was attended by distinguished members, including Dr. Naseem, Consultant Infectious Diseases, PIMS; Dr. Nadia Shams, Medical Specialist; Dr. Fawad Khalid, ADHO, Islamabad; Prof. Dr. Salman, Pharmacologist; Mr. Waqas Ahmed, Clinical Pharmacist; the Drug Insoectors and Sardar Shabbir Ahmed, SQCB/Focal Person Pharmacovigilance, Islamabad.
The Committee was briefed by the Focal Person and Convener on the current pharmacovigilance activities being undertaken in Islamabad, including initiatives aimed at strengthening ADR reporting, improving awareness among healthcare professionals, and enhancing the overall pharmacovigilance system.
The Committee held an in-depth discussion on strategies to increase both the number and quality of Adverse Drug Reaction (ADR) reports from healthcare facilities across Islamabad. Particular emphasis was placed on strengthening institutional reporting mechanisms, improving the capacity and engagement of healthcare professionals, promoting timely and complete reporting, and ensuring effective feedback and follow-up mechanisms.
As a gesture of recognition and encouragement, appreciation certificates were presented to the Pharmacovigilance Focal Persons of the highest-reporting healthcare institutions, including Shifa Hospital, Pakistan Institute of Medical Sciences (PIMS), Ali Medical Centre, Akbar Niazi Hospital, and Rawal Hospital, in acknowledgment of their valuable contribution towards strengthening pharmacovigilance and promoting patient safety.
The Committee reaffirmed its commitment to further strengthening the pharmacovigilance system in Islamabad through collaborative efforts, capacity building, active surveillance, improved ADR reporting, and continuous engagement with healthcare institutions and professionals, with the ultimate objective of ensuring safer and more rational use of medicines and improved patient safety.